|

Arthritis Clinical Trials in Texas

63 recruiting studies across 7 cities

Browse by City

Houston
43 trials
Arlington
35 trials
Dallas
35 trials
Fort Worth
35 trials
San Antonio
12 trials
Austin
10 trials
El Paso
4 trials

All Trials in Texas

Phase
Trial Phase Dist.
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.Phase 2<1 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate ResponsePhase 3<1 mi
Study of GS-0151 in Participants With Rheumatoid ArthritisPhase 1<1 mi
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic PainPhase 2<1 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or OverweightPhase 3<1 mi
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid ArthritisPhase 2<1 mi
A Study of Dotinurad Versus Allopurinol in Participants With GoutPhase 3<1 mi
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout ParticipantsPhase 2<1 mi
ConsideRAte Study - Splenic Stimulation for RAN/A<1 mi
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.Phase 3<1 mi
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and OsteoarthritisPhase 3<1 mi
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid ArthritisPhase 2<1 mi
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic ArthritisPhase 3<1 mi
Safety and Efficacy of ABP-745 in Participants With an Acute Gout FlarePhase 2<1 mi
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or AdalimumabPhase 3<1 mi
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic ArthritisPhase 2<1 mi
MOTION Clinical TrialN/A<1 mi
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce PainPhase 3<1 mi
COMPARATIVE EFFECTIVENESS OF EXERCISE, COGNITIVE BEHAVIOURAL THERAPY, AND THEIR COMBINATION FOR PEOPLE WITH CHRONIC MUSCULOSKELETAL PAIN AND POOR SLEEP: SLEEPFIT TRIALN/A<1 mi
MultiCenter IDE Study of the PEEK-OPTIMA™ Femoral Component vs a CoCr Alloy TKA Femoral Component of Similar DesignN/A<1 mi
Guselkumab vs Golimumab in PsA TNF Inadequate Responder PatientsPhase 3<1 mi
RA-PRO PRAGMATIC TRIALPhase 3<1 mi
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).Phase 1<1 mi
Upper and Lower Extremity Exercise and Exercise-Induced Hypoalgesia in Knee OsteoarthritisN/A<1 mi
Phase 3 Study of Telitacicept in Active Primary Sjögren's DiseasePhase 3<1 mi
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)Phase 4<1 mi
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPhase 1<1 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesPhase 3<1 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry—<1 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the KneePhase 3<1 mi
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)Phase 1/2<1 mi
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)Phase 2<1 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesPhase 3<1 mi
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors—<1 mi
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)Phase 2<1 mi
R-2487 in Patients With Rheumatoid ArthritisPhase 1<1 mi
A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy—<1 mi
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune DiseasesPhase 2<1 mi
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic—<1 mi
Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle ArthroplastyPhase 4<1 mi
The Myelin Disorders Biorepository Project—<1 mi
A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)Phase 2<1 mi
Continuation Study of Zasocitinib in Adults With Psoriatic ArthritisPhase 3<1 mi
Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)Phase 2<1 mi
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid ArthritisPhase 2<1 mi
Ultrasound Neuroimmune Modulation in Adults With Rheumatoid ArthritisN/A<1 mi
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic ArthritisPhase 3<1 mi
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce PainPhase 3<1 mi
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease—7 mi
FX Shoulder Prospective Clinical Study—8 mi
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsPhase 110 mi
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)Phase 310 mi
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE ParticipantsPhase 112 mi
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's DiseasePhase 118 mi
MDR - PMCF Study for Taperloc Complete Stems—18 mi
Phase 1b/2 Study of IV Sarilumab in Adult With RAPhase 1/218 mi
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)Phase 118 mi
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom BurdenPhase 324 mi
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic ArthritisPhase 226 mi
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar PainPhase 144 mi
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee OsteoarthritisEarly 144 mi
Primary Subtalar Arthrodesis for Calcaneal FracturesN/A47 mi
Vibratory Anesthesia on Pain Following Corticosteroid InjectionsN/A47 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.